Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapyKoichiro Yamamoto, Hisao Ogawa, Tomohide Abe et al.|Journal of Cardiology|2010Cited by 100
Assessment of platelet‐derived thrombogenicity with the total thrombus‐formation analysis system in coronary artery disease patients receiving antiplatelet therapyYuichiro Arima, Hisao Ogawa, Masanobu Ishii et al.|Journal of Thrombosis and Haemostasis|2016Cited by 55